Neurology Live just reported on his article in the Journal of Alzheimer's Disease Reports! You can listen to the 6 min audio version. They highlight that this is the first time ever that anyone has lowered and reversed p-tau 217, the most specific and sensitive biomarker for Alzheimer's Disease using a 9 week oral antibiotic protocol that addresses the biofilm/persister forms of Borrelia!
“A 67-year-old with long-standing chronic Lyme disease received dapsone, rifampin, azithromycin, tetracycline, and methylene blue with supportive measures over nine weeks.
• Plasma p-tau217 fell 63% into the normalized range, and amyloid-B42/40 ratio increased, with reported improvements in recall and concentration.”
* reduction in plasma p-tau217 from 0.33 pg/mL to 0.12 pg/mL (63% decrease; normalized range)
• Improvement in amyloid-B 42/40 ratio from 0.185 to 0.216
• Reduction in rheumatoid factor from 20 IU/mL to within normal limits
These biomarker changes were accompanied by patient-reported improvements in cognition, including memory recall and concentration, as well as reduced joint symptoms. Repeat laboratory testing conducted 2-3 months post-treatment confirmed normalization of inflammatory and neurodegenerative markers, including sustained reductions in p-tau217 and stable amyloid ratios.
Congratulations Dr Horowitz 💚❤️💚❤️💚❤️💚❤️💚❤️
Posted by hiker53 (Member # 6046) on :
Thanks, Bonnie, for posting this.
Autopsies of many Alzheimer's patients have shown Lyme in the brain for years.
Nice to have confirmation and some medical reversal.